Pagliaro, R.; Vitiello, F.; Gilli, M.; d’Orologio, A.; Borgese, L.; Campbell, S.F.; Medusa, P.M.; Signoriello, G.; Perrotta, F.; Rocco, D.;
et al. Effectiveness of Atezolizumab in Addition to Chemotherapy in ES-SCLC: A Retrospective Real-World Monocentric Study. Cancers 2025, 17, 3298.
https://doi.org/10.3390/cancers17203298
AMA Style
Pagliaro R, Vitiello F, Gilli M, d’Orologio A, Borgese L, Campbell SF, Medusa PM, Signoriello G, Perrotta F, Rocco D,
et al. Effectiveness of Atezolizumab in Addition to Chemotherapy in ES-SCLC: A Retrospective Real-World Monocentric Study. Cancers. 2025; 17(20):3298.
https://doi.org/10.3390/cancers17203298
Chicago/Turabian Style
Pagliaro, Raffaella, Fabiana Vitiello, Marina Gilli, Antonio d’Orologio, Luca Borgese, Susan F. Campbell, Paola Maria Medusa, Giuseppe Signoriello, Fabio Perrotta, Danilo Rocco,
and et al. 2025. "Effectiveness of Atezolizumab in Addition to Chemotherapy in ES-SCLC: A Retrospective Real-World Monocentric Study" Cancers 17, no. 20: 3298.
https://doi.org/10.3390/cancers17203298
APA Style
Pagliaro, R., Vitiello, F., Gilli, M., d’Orologio, A., Borgese, L., Campbell, S. F., Medusa, P. M., Signoriello, G., Perrotta, F., Rocco, D., & Bianco, A.
(2025). Effectiveness of Atezolizumab in Addition to Chemotherapy in ES-SCLC: A Retrospective Real-World Monocentric Study. Cancers, 17(20), 3298.
https://doi.org/10.3390/cancers17203298
